Big #Cancer52 Conversation
Insightful discussions on reducing health inequalities
A lively conference was held on the 13th November called the Big #Cancer52 Conversation. There were insightful discussions focused on reducing health inequalities with new Cancer52 CEO, Chris Walden, our very own Oracle Head & Neck Cancer UK CEO, Tamara Kahn, Director of Delivery & Impact, Roz Redd, and North West Cancer Research (NWCR) CEO, Alastair Richards, amongst many other amazing partners and key cancer charity, policy and research leaders.
Highlight talk by Prof. Bola Owolabi, NHS England’s Director of Healthcare Inequalities Improvement and practicing GP, emphasising our collective responsibility to drive change through our spheres of influence.
A lot to do on stark inequalities
And we have our work ahead! As the Big #Cancer52 Conversation demonstrated, Head and neck cancers have many stark inequalities:
- 2x higher incidence in most deprived areas vs least deprived
- Up to 55% of cases diagnosed at late stages
- Significant survival rate disparities across regions
As the recent University of Sheffield and Department of Health and Social Care atlas of health variation across England reported;
People living in the most deprived areas were more likely to be diagnosed with head and neck cancer at a late stage than those living in the least deprived areas. Reasons may include lower health literacy, poorer communication of healthcare needs and poorer access to dental services.
In 2020, 3,469 people died of head and neck cancers in England alone, an increase from 3,313 deaths in 2019. The mortality rate for head and neck cancer continued to increase in 2020 while for all cancers the mortality rate decreased.
There was significant geographic variation in mortality rates across England. People living in the most deprived areas have more than double the mortality rate of those living in the least deprived areas.
Oracle is committed to putting head and neck cancers firmly on the map in the new 10-year cancer plan. Working with our Head & Neck Cancer Coalition partners, we have a crucial opportunity to reshape the landscape of care.
Following Lord Darzi’s 2024 NHS investigation, the urgency is clear: we must amplify voices of underserved communities and transform treatment accessibility. The diagnosis is made – now we focus on the cure.
Together, we can make a difference!
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Leadership update
After four successful years as CEO, Tamara Kahn has transformed Oracle into a respected national voice for head and neck cancer patients. She established a national presence, created a four-pillar RACE strategy (Research, Awareness, Collaboration and Patient/Community Engagement) and built strong policy influence. With these foundations now firmly in place, Tamara will transition from her…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Join Us for an Evening of Research, Impact, and Conversation
Research & Impact EveningDate: Monday 28th April 2025Time: 6:00 PM – 8:30 PMVenue: Skyline, Tower Suites, 100 Minories, London EC3N 1JY A Celebration of Research Join us for a meaningful and action-focused evening where we’ll be diving into some of the big conversations around head and neck cancer – especially those linked to HPV (human…
What the Rare Cancers Bill Means for Head & Neck Cancer
14 March marked a crucial moment for research into rare cancers, as the Rare Cancers Bill took another significant step toward becoming law! Dr. Scott Arthur, a Labour MP, introduced this legislation in Parliament to drive much-needed research into cancers affecting fewer than 1 in 2000 people in the UK – including many types of…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 80 Coombe Road, New Malden KT3 4QS.